Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis.

Wollenberg, A; Sidhu, M K; Odeyemi, I; Dorsch, B; Koehne-Volland, R; Schaff, M; Ehlken, B; Berger, K

Wollenberg, A; Sidhu, M K; Odeyemi, I; Dorsch, B; Koehne-Volland, R; Schaff, M; Ehlken, B; Berger, K.

Affiliation

Wollenberg A; Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians Universität, Munich, Germany.

Br J Dermatol ; 159(6): 1322-30, 2008 Dec.

Article in En | MEDLINE | ID: mdl-18782316

Subject(s)

Dermatitis, Atopic/drug therapy; Immunosuppressive Agents/economics; Tacrolimus/economics; Adult; Cost-Benefit Analysis; Dermatitis, Atopic/economics; Drug Administration Schedule; Female; Health Care Costs; Health Status; Humans; Immunosuppressive Agents/therapeutic use; Male; Quality of Life; Tacrolimus/therapeutic use; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tacrolimus / Dermatitis, Atopic / Immunosuppressive Agents Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Br J Dermatol Year: 2008 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google